Ayurvedic management of Uterine leiomyoma

Effect of Kapha-arbudahar Oiluttarbasti on uterine fibroid

Status

Active, not recruiting

Phases

Phase 2

Study type

Interventional

Source

CTRI

Registry ID

CTRI/2022/05/042372

Enrollment

Registered

2022-05-04

Start date

Unknown

Completion date

Unknown

Last updated

2025-09-15

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Health Condition 1: D259- Leiomyoma of uterus, unspecified

Interventions

None listed

Eligibility

Inclusion criteria

Inclusion criteria: 1. Married women who are diagnosed with uterine fibroid on USG or CT 2. Fibroid size

Exclusion criteria

Exclusion criteria: 1. Unmarried 2. Menopausal 3. PID 4. Carcinoma 5. Fibroid size > 7 cm

Design outcomes

Primary

Measure	Time frame
Assessment will be done on the basis of fibroid size seen in USG or CT, Relief in lower abdominal pain, Decrease in the amount of Menstrual bleeding, Duration of Menstruation, Interval of Menstrual CycleTimepoint: Pretreatment 4th week - 1st Follow up 8th week - 2nd Follow up 12th week - 3rd Follow up	—

Secondary

Measure	Time frame
Fibroid Size Amount of Menstrual bleeding Duration of Menstruation Interval of Menstrual CycleTimepoint: 1 month after completion of treatment 6 months after completion of treatment	—

Countries

India

Contacts

Public ContactDr Shikha Singh

Banaras Hindu University

shikha151984@gmail.com9140457623

Outcome results